gwfish: A simulation software to evaluate parameter-estimation capabilities of gravitational-wave detector networks by Dupletsa, U., Harms, J., Banerjee, B., Branchesi, M., Goncharov, B., Maselli, A., Oliveira, A.C.S., Ronchini, S., Tissino, J.

Get full text

Human RECQ1 and RECQ4 Helicases Play Distinct Roles in DNA Replication Initiation by Thangavel, Saravanabhavan, Mendoza-Maldonado, Ramiro, Tissino, Erika, Sidorova, Julia M., Yin, Jinhu, Wang, Weidong, Monnat, Raymond J., Falaschi, Arturo, Vindigni, Alessandro

Get full text

CXCR4 Loss Reduces the Local Growth of Richter Syndrome Murine and Patient-Derived Xenograft Models and Impairs BCR and VLA-4 Activation by Martines, Claudio, Chakraborty, Supriya, Zucchetto, Antonella, Tissino, Erika, Guastafierro, Vincenzo, Vujovikj, Marija, Vaisitti, Tiziana, Deaglio, Silvia, Laurenti, Luca, Dimovski, Aleksandar J, Gattei, Valter, Efremov, Dimitar G

Get full text

P606: MEASUREMENT OF INTRACLONAL DIVERSIFICATION REFINES THE PROGNOSTIC IMPACT OF IGHV MUTATIONS IN CLL by Vit, Filippo, Bittolo, Tamara, Papotti, Robel, Pozzo, Federico, Zucchetto, Antonella, Tissino, Erika, Zaina, Eva, Catarossi, Ilaria, Laureana, Roberta, Olivieri, Jacopo, Bulian, Pietro, Levato, Luciano, D’arena, Giovanni, Armiento, Daniele, Zamò, Alberto, Leich, Ellen, Rosenwald, Andreas, Arons, Evgeny, J. Kreitman, Robert, Gentile, Massimo, Laurenti, Luca, Zaja, Francesco, Tafuri, Agostino, Chiarenza, Annalisa, Ilaria DEL Principe, Maria, Gattei, Valter, Bomben, Riccardo

Get full text

P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE by Bomben, R., Rossi, F. M., Vit, F., Bittolo, T., Zucchetto, A., Papotti, R., Tissino, E., Pozzo, F., Degan, M., Zaina, E., Cattarossi, I., Nanni, P., Marasca, R., Reda, G., Laurenti, L., Olivieri, J., Chiarenza, A., Ballotta, L., Cuneo, A., Gentile, M., Morabito, F., Tafuri, A., Zaja, F., Foà, R., Di Raimondo, F., Del Poeta, G., Gattei, V.

Get full text

INSIDE‐OUT VLA‐4 INTEGRIN ACTIVATION IS MAINTAINED IN IBRUTINIB‐TREATED CHRONIC LYMPHOCYTIC LEUKEMIA EXPRESSING CD49D: CLINICAL RELEVANCE by Tissino, E., Benedetti, D., Herman, S.E., Hacken, E., Ahn, I.E., Chaffee, K.G., Bayer, E., Haerzschel, A., Gutjahr, J.C., Postorino, M., Santinelli, E., Ayed, A., Zaja, F., Chiarenza, A., Chigaev, A., Sklar, L.A., Burger, J.A., Ferrajoli, A., Shanafelt, T.D., Wiestner, A., Del Poeta, G., Hartmann, T.N., Gattei, V., Zucchetto, A.

Get full text

ADAPTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO IBRUTINIB IS MEDIATED BY EPIGENETIC PLASTICITY OF RESIDUAL DISEASE AND BY‐PASS SIGNALING VIA MAPK PATHWAY by Terzi di Bergamo, L, Forestieri, G, Loh, J. W, Singh, A, Spina, V, Zucchetto, A, Condoluci, A, Faderl, M, Koch, R, Bruscaggin, A, Pini, K, Wu, W, Piffaretti, D, Bittolo, T, Tissino, E, De Paoli, L, Deambrogi, C, Frustaci, A. M, Autore, F, Merli, M, Scarfò, L, Rasi, S, Passweg, J, Moia, R, Martines, C, Ghia, P, Cavalli, F, Zucca, E, Gerber, B, Gillessen, S, Stüssi, G, Montillo, M, Passamonti, F, Gregor, M, Laurenti, L, Tedeschi, A, Gaidano, G, Efremov, D, Gattei, V, Khiabanian, H, Rossi, D

Get full text